Bio-Techne Q1 Adjusted EPS $0.41 Misses $0.44 Estimate, Sales $276.94M Miss $287.77M Estimate
Portfolio Pulse from Benzinga Newsdesk
Bio-Techne reported Q1 earnings of $0.41 per share, missing the analyst consensus estimate of $0.44 by 6.82%. This is a decrease of 8.89% from the same period last year. The company also reported quarterly sales of $276.94 million, missing the analyst consensus estimate of $287.77 million by 3.77%. However, this is a 2.70% increase over sales from the same period last year.
October 31, 2023 | 10:38 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Bio-Techne's Q1 earnings and sales missed estimates, which could negatively impact the stock in the short term.
Bio-Techne's earnings and sales missed estimates, which is typically seen as a negative signal by the market. This could lead to a decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100